Document:

EX-10.2 GMP AMENDMENT NO.16 TO THE AGREEMENT

 

EXHIBIT 10.2

GMP AMENDMENT NUMBER 16

     This Separate GMP Amendment is executed this 4th day of February, 2008, by Gaylord
National, LLC (“Owner”) and Perini Tompkins Joint Venture (“Construction Manager”) pursuant to the
Agreement dated May 9, 2005 (“Agreement”) executed by the parties for the performance by the
Construction Manager of certain construction work and construction management services for the
Gaylord National Harbor Resort and Convention Center Project as identified therein.

	 	1.	 	Pursuant to the Agreement, Construction Manager hereby agrees that the
Guaranteed Maximum Price (“GMP”) for the Work to be performed on the Project (including
all Work under this GMP Amendment Number 16 and all Work previously authorized pursuant
to GMP Amendments shall be $771,618,711 and that the GMP is accounted as follows: (a)
the Preconstruction Services equals $350,000, (b) the Construction Manager’s Lump Sum
General Conditions equals $24,459,680, (c) the Cost of the Work equals $709,093,668,
(d) the Construction Manager’s Fee equals $21,525,860, (e) Contingency equals
$15,938,947, (f) the Mock-up Room Cost of Work equals $250,557.

	 	 	 
	OWNER

	 	CONSTRUCTION MANAGER
	GAYLORD NATIONAL, LLC

	 	PERINI TOMPKINS JOINT VENTURE
	By: Gaylord Hotels, Inc. sole member
	 	 

	 	 	 	 	 	 	 
	By:

	 	/s/ David C. Kloeppel
	 	By:
	 	/s/ Mark Makary
	 

	 	     David C. Kloeppel
	 	 	 	     Mark Makary
	Title:

	 	Vice-President
	 	Title:
	 	Principal-in-ChargeEX-10.3 GMP AMENDMENT NO.17 TO THE AGREEMENT

 

EXHIBIT 10.3

GMP AMENDMENT NUMBER 17

     This Separate GMP Amendment is executed this 4th day of February, 2008, by Gaylord
National, LLC (“Owner”) and Perini Tompkins Joint Venture (“Construction Manager”) pursuant to the
Agreement dated May 9, 2005 (“Agreement”) executed by the parties for the performance by the
Construction Manager of certain construction work and construction management services for the
Gaylord National Harbor Resort and Convention Center Project as identified therein.

	 	1.	 	Pursuant to the Agreement, Construction Manager hereby agrees that the
Guaranteed Maximum Price (“GMP”) for the Work to be performed on the Project (including
all Work under this GMP Amendment Number 17 and all Work previously authorized pursuant
to GMP Amendments shall be $737,656,945 and that the GMP is accounted as follows: (a)
the Preconstruction Services equals $350,000, (b) the Construction Manager’s Lump Sum
General Conditions equals $24,459,680, (c) the Cost of the Work equals $675,131,901,
(d) the Construction Manager’s Fee equals $21,525,860, (e) Contingency equals
$15,938,947, (f) the Mock-up Room Cost of Work equals $250,557.

	 	 	 
	OWNER

	 	CONSTRUCTION MANAGER
	GAYLORD NATIONAL, LLC

	 	PERINI TOMPKINS JOINT VENTURE
	By: Gaylord Hotels, Inc. sole member
	 	 

	 	 	 	 	 	 	 
	By:

	 	/s/ David C. Kloeppel
	 	By:
	 	/s/ Gary Sapowski
	 

	 	     David C. Kloeppel
	 	 	 	     Gary Sapowski
	Title:

	 	Vice-President
	 	Title:
	 	Sr. VPEX-10.4 GMP AMENDMENT NO.18 TO THE AGREEMENT

 

EXHIBIT 10.4

GMP AMENDMENT NUMBER 18

     This Separate GMP Amendment is executed this 4th day of February 2008, by Gaylord
National, LLC (“Owner”) and Perini Tompkins Joint Venture (“Construction Manager”) pursuant to the
Agreement dated May 9, 2005 (“Agreement”) executed by the parties for the performance by the
Construction Manager of certain construction work and construction management services for the
Gaylord National Harbor Resort and Convention Center Project as identified therein.

	 	1.	 	Pursuant to the Agreement, Construction Manager hereby agrees that the
Guaranteed Maximum Price (“GMP”) for the Work to be performed on the Project (including
all Work under this GMP Amendment Number 18 [sic] and all Work previously authorized
pursuant to GMP Amendments shall be $741,394,328 and that the GMP is accounted as
follows: (a) the Preconstruction Services equals $350,000, (b) the Construction
Manager’s Lump Sum General Conditions equals $24,459,680, (c) the Cost of the Work
equals $678,869,285, (d) the Construction Manager’s Fee equals $21,525,860, (e)
Contingency equals $15,938,947, (f) the Mock-up Room Cost of Work equals $250,557.

	 	 	 
	OWNER

	 	CONSTRUCTION MANAGER
	GAYLORD NATIONAL, LLC

	 	PERINI TOMPKINS JOINT VENTURE
	By: Gaylord Hotels, Inc. sole member
	 	 

	 	 	 	 	 	 	 
	By:

	 	/s/ David C. Kloeppel
	 	By:
	 	/s/ Mark Makary
	 

	 	     David C. Kloeppel
	 	 	 	     Mark Makary
	Title:

	 	Vice-President
	 	Title:
	 	Principal-in-ChargeEx-10.1 Subscription Agreement dated February 6

 

EXHIBIT
10.1

EXECUTION COPY

SUBSCRIPTION AGREEMENT

     This
Subscription Agreement (this “Agreement”) is dated as of February 6, 2008, among
MBF Healthcare Acquisition Corp., a Delaware corporation (the
“Company”), and the purchasers
identified on the signature pages hereto (each, an
“Purchaser” and collectively, the
“Purchasers”).

     WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to
Section 4(2) of the Securities Act (as defined below) and Rule 506 promulgated thereunder, the
Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly,
desires to purchase from the Company certain securities of the Company, as more fully described in
this Agreement.

     NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for
other good and valuable consideration the receipt and adequacy of which are hereby acknowledged,
the Company and the Purchasers agree as follows:

ARTICLE I

DEFINITIONS

     1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, for all
purposes of this Agreement, the following terms shall have the meanings indicated in this
Section 1.1:

     “Action” means any action, suit, inquiry, notice of violation, proceeding (including any
partial proceeding such as a deposition) or investigation pending or threatened in writing against
or affecting the Company or any of its respective properties before or by any court, arbitrator,
governmental or administrative agency, regulatory authority (federal, state, county, local or
foreign), stock market, stock exchange or trading facility.

     “Affiliate” means any Person that, directly or indirectly through one or more
intermediaries, controls or is controlled by or is under common control with a Person, as such
terms are used in and construed under Rule 144.

     “Aggregate
Investment Amount” means the aggregate of all Investment Amounts, which amount
shall be Thirty Five Million Dollars ($35,000,000).

     “Business
Day” means any day except Saturday, Sunday and any day which shall be a federal
legal holiday or a day on which banking institutions in the State of New York are authorized or
required by law or other governmental action to close.

     “CHS” has the meaning ascribed to such term in the definition of the CHS Transaction.

     “CHS
Transaction” means the purchase by the Company of all of the issued and outstanding
capital stock of Critical Homecare Solutions Holdings, Inc., a Delaware corporation (“CHS”),
pursuant to a Stock Purchase Agreement by and among the Company, CHS, Kohlberg Investors V, L.P., a
Delaware limited partnership, as Purchasers’ representative, and the Purchasers (the “Stock
Purchase Agreement”).

     “Closing” means the closing of the purchase and sale of the Shares pursuant to Section 2.1.

     “Closing Date” means the date of the Closing, which date shall be the same day upon which
the closing of the CHS Transaction occurs, following the satisfaction of each of the conditions
applicable to the Closing as set forth in Section 2.2 hereof.

     “Commission” means the Securities and Exchange Commission.

     “Common Stock” means the common stock of the Company, $0.0001 par value per share.

 

 

     “Disclosure Package” means (i) the Prospectus and (ii) each “free writing prospectus” as
defined in Rule 405 promulgated under the Securities Act.

     “Exchange Act” means the Securities Exchange Act of 1934, as amended.

     “Filing Date” means, with respect to the Registration Statement required to be filed
hereunder, the 30th calendar day following the Closing Date.

     “Investment Amount” means, with respect to each Purchaser, the investment amount indicated
below such Purchaser’s name on the signature page of this Agreement.

     “Lien” means any lien, charge, encumbrance, security interest, right of first refusal,
preemptive right or other restrictions of any kind.

     “Material Adverse Effect” means a material adverse effect on the business, results of
operations, properties or assets of the Company; provided, however, that
“Material Adverse Effect” shall not include the impact on such business, results of
operations, properties or assets arising out of or attributable to (i) effects or conditions
resulting from an outbreak or escalation of hostilities, acts of terrorism, political instability
or other national or international calamity, crisis or emergency, or any governmental or other
response to any of the foregoing, in each case whether or not involving the United States (in each
case, that do not disproportionately affect the Company relative to other businesses in the
industry in which the Company operates), (ii) effects arising from changes in laws or GAAP,
(iii) effects relating to the announcement of the execution of this Agreement or the transactions
contemplated hereby, or (iv) effects resulting from compliance with the terms and conditions of
this Agreement or the Stock Purchase Agreement by the Company.

     “Per Share Purchase Price” equals $7.65.

     “Person” means an individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any kind.

     “Prospectus” means the prospectus included in the Registration Statement (including, without
limitation, a prospectus that includes any information previously omitted from a prospectus filed
as part of an effective registration statement in reliance upon Rule 430A promulgated under the
Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms
of the offering of any portion of the Shares covered by the Registration Statement, and all other
amendments and supplements to the Prospectus, including post-effective amendments, and all material
incorporated by reference or deemed to be incorporated by reference in such Prospectus.

     “Registration Statement” means the registration statement required to be filed hereunder,
including the Prospectus, amendments and supplements to the registration statement or Prospectus,
including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in the Registration Statement.

     “Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as
such Rule may be amended from time to time, or, to the extent replaced, the comparable successor
thereto.

     “Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as
such Rule may be amended from time to time, or, to the extent replaced, the comparable successor
thereto.

     “Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as
such Rule may be amended from time to time, or, to the extent replaced, the comparable successor
thereto.

     “SEC Reports” shall have the meaning ascribed to such term in Section 3.1(g).

2

 

     “Securities” means the Shares.

     “Securities Act” means the Securities Act of 1933, as amended.

     “Shares” means the shares of Common Stock issued or issuable to the Purchasers pursuant to
this Agreement.

     “Stock Purchase Agreement’’ has the meaning ascribed to such term in the definition of CHS
Transaction.

     “Trading Day” means (i) a day on which the Common Stock is traded on a Trading Market, or
(ii) if the Common Stock is not listed or admitted for trading on a Trading Market, a day on which
the Common Stock is traded in the over-the-counter market is quoted in the over-the-counter market
as reported by the National Quotation Bureau Incorporated (or any similar organization or agency
succeeding to its functions of reporting prices); provided, that in the event that the Common Stock
is not listed or quoted as set forth in (i) or (ii) hereof, then Trading Day shall mean a Business
Day.

     “Trading Market” means the American Stock Exchange (“AMEX”) or, if the Company’s Common
Stock is not listed on AMEX, such other exchange or quotation system on which the Common Stock is
listed or quoted for trading on the date in question.

     “Transaction Documents” means this Agreement, the Escrow Agreement and any other documents
or agreements executed in connection with the transactions contemplated hereunder.

ARTICLE II

PURCHASE AND SALE

     2.1 Closing; Escrow.

          (a) Subject to the terms and conditions set forth in this Agreement, at the Closing the
Company shall issue and sell to each Purchaser, and each Purchaser shall purchase from the
Company, the Shares representing such Purchaser’s Investment Amount. Promptly upon the
satisfaction of each of the applicable conditions set forth in Section 2.2, the Closing
shall occur at the offices of Akerman Senterfitt, One Southeast 3rd Avenue, Suite
2500, Miami, Florida 33131or at such other location or time as the parties shall mutually
agree.

          On the date of the CHS Transaction closing, the Company shall have, and the Purchasers
hereby grant to the Company, the right to deduct the Aggregate Investment Amount from the
Estimated Purchase Price (as such term is defined in the Stock Purchase Agreement) otherwise
payable to the Purchasers under the terms of the Stock Purchase Agreement.

     2.2 Closing Conditions.

          (a) At the Closing, the Company shall deliver or cause to be delivered to each
Purchaser a certificate evidencing a number of Shares registered in the name of such
Purchaser or a book-entry transfer of the Shares to such Purchaser equal to such Purchaser’s
Investment Amount divided by the Per Share Purchase Price. The Company will not issue any fractional Shares and, instead, each Purchaser’s
Investment Amount will be reduced by an amount equal to the Per Share Purchase Price multiplied by
the fractional share interest to which the Purchaser would otherwise be entitled.

          (b) The obligations of each party at the Closing to consummate the transactions
contemplated at the Closing shall be subject to the satisfaction or waiver of all of the
conditions to closing the CHS Transaction set forth in the Stock Purchase Agreement.

3

 

ARTICLE III

REPRESENTATIONS AND WARRANTIES

     3.1 Representations and Warranties of the Company. The Company hereby makes the following
representations and warranties to each Purchaser:

          (a) Organization and Qualification. The Company is an entity duly incorporated,
validly existing and in good standing under the laws of the State of Delaware, with the
requisite power and authority to own and use its properties and assets and to carry on its
business as currently conducted. The Company is not in violation of any of the provisions
of its certificate of incorporation or bylaws. The Company is duly qualified to conduct
business and is in good standing as a foreign corporation in each jurisdiction in which the
nature of the business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may be, would
not, individually or in the aggregate, reasonably be expected to result in a Material
Adverse Effect and no Action has been instituted in any such jurisdiction revoking, limiting
or curtailing or seeking to revoke, limit or curtail such power and authority or
qualification.

          (b) Authorization; Enforcement. Other than the Buyer Stockholder Approval (as such
term is defined in the Stock Purchase Agreement), the Company has all requisite corporate
power and authority, and has taken all requisite corporate action to enter into and to
consummate the transactions contemplated by each of the Transaction Documents and otherwise
to carry out its obligations thereunder. The execution and delivery of each of the
Transaction Documents by the Company and the consummation by it of the transactions
contemplated thereby have been duly authorized by all necessary action on the part of the
Company and no further action is required by the Company in connection therewith, except for
the Buyer Stockholder Approval. Each Transaction Document has been (or upon delivery will
have been) duly executed by the Company and, when delivered in accordance with the terms
hereof, will constitute the valid and binding obligation of the Company enforceable against
the Company in accordance with its terms, except as limited by (i) applicable bankruptcy,
insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors’ rights generally and (ii) general principles of equity.

          (c) No Conflicts. Other than the Buyer Stockholder Approval, the execution, delivery
and performance of the Transaction Documents by the Company and the consummation by the
Company of the transactions contemplated thereby do not and will not (i) conflict with or
violate any provision of the Company’s certificate of incorporation or bylaws, or
(ii) conflict with, or constitute a default (or an event that with notice or lapse of time
or both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation (with or without notice, lapse of time or both) of,
any agreement, credit facility, debt or other instrument (evidencing a Company debt or
otherwise) or other understanding to which the Company is a party or by which any property
or asset of the Company is bound or affected, or (iii) result in a violation of any law,
rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company is subject (including federal and state
securities laws and regulations), or by which any property or asset of the Company is bound
or affected; except in the case of clause (iii), such as would not, individually or in the
aggregate, reasonably be expected to be material to the business or the operation of the
Company or materially impair the Company’s ability to consummate the transaction
contemplated hereby.

          (d) Filings, Consents and Approvals. Other than the Buyer Stockholder Approval, the
Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state,
local or other governmental authority or other Person in connection with the execution,
delivery and performance by the Company of the Transaction Documents, other than (i) the
filing of Form D with the Commission and such filings required by state securities laws,
which the Company will promptly and timely make, and (ii) such other filings as may be
required following the Closing Date under the Securities Act and the Exchange Act.

          (e) Issuance of the Securities. The Shares have been duly authorized and, when issued
and paid for in accordance with the Transaction Documents, will be duly and validly issued,
fully

4

 

paid and nonassessable, free and clear of all Liens and preemptive rights. The Company
has reserved from its duly authorized capital stock all of the Shares issuable pursuant to
this Agreement.

          (f) Capitalization. The capitalization of the Company conforms as to legal matters to
the description thereof contained in the Company’s most recent periodic report filed with
the Commission at least two Business Days prior to the date hereof. No securities of the
Company are entitled to preemptive or similar rights, and no Person has any right of first
refusal, preemptive right, right of participation, or any similar right to participate in
the transactions contemplated by the Transaction Documents. The Company has no authorized or
outstanding bonds, debentures, notes or other indebtedness the holders of which have the
right to vote (or convertible into, exchangeable for, or evidencing the right to subscribe
for or acquire securities having the right to vote). All of the outstanding shares of
capital stock of the Company are validly issued, fully paid and nonassessable, have been
issued in compliance with all federal and state securities laws, and none of such
outstanding shares was issued in violation of any preemptive rights or similar rights to
subscribe for or purchase securities. In connection with the CHS Transaction, on the Closing
Date, the Company will issue Fifty Million Dollars ($50,000,000) of common stock pursuant to
a private placement and such shares shall be sold at a price per share no less than the Per
Share Purchase Price. Other than the Buyer Stockholder Approval, no further approval or
authorization of any stockholder, the Board of Directors of the Company or others is
required for the issuance and sale of the Shares. Except as disclosed in the SEC Reports,
there are no stockholders agreements, voting agreements or other similar agreements with
respect to the Company’s capital stock to which the Company is a party or, to the knowledge
of the Company, between or among any of the Company’s stockholders.

          (g) SEC Reports; Financial Statements. The Company has filed all reports,
registrations, schedules, forms, statements and other documents required to be filed by it
under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or
15(d) thereof, or with any Governmental Authority, for the twelve months preceding the date
hereof (or such shorter period as the Company was required by law to file such reports) (the
foregoing materials being collectively referred to herein as the
“SEC Reports”) on a
timely basis or has timely filed a valid extension of such time of filing and has filed any
such SEC Reports prior to the expiration of any such extension. As of their respective
dates, the SEC Reports complied in all material respects with the requirements of the
Securities Act and the Exchange Act and the rules and regulations of the Commission
promulgated thereunder, and the rules and regulations of any other Governmental Authority
with which the SEC Reports were made or should have been made, and none of the SEC Reports,
when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading. The financial
statements of the Company included in the SEC Reports comply in all material respects with
the rules and regulations of the Commission with respect thereto as in effect at the time of
filing. Such financial statements have been prepared in accordance with generally accepted
accounting principles applied on a consistent basis during the
periods involved (“GAAP”),
except as may be otherwise specified in such financial statements or the notes thereto and
except that unaudited financial statements may not contain all footnotes required by GAAP,
and fairly present in all material respects the financial position of the Company and its
consolidated subsidiaries as of and for the dates thereof and the results of operations and
cash flows for the periods then ended, subject, in the case of unaudited statements, to
normal, immaterial, year-end audit adjustments.

     3.2 Representations and Warranties of the Purchasers. Each Purchaser hereby, for itself and
for no other Purchaser, represents and warrants on a several (and not a joint or joint and several
basis) and as of the Closing Date to the Company as follows:

          (a) Organization; Authority. Such Purchaser is either (i) an entity duly organized,
validly existing and in good standing under the laws of the jurisdiction of its organization
or (ii) an individual, with the requisite corporate or partnership power and authority or
capacity, as applicable, to enter into and to consummate the transactions contemplated by
the applicable Transaction Documents and otherwise to carry out its, his or her obligations
thereunder. The execution, delivery and performance by such Purchaser (if not an
individual) of the transactions contemplated by this Agreement has been duly authorized by
all necessary corporate or, if such Purchaser is not a corporation, such partnership,
limited liability company or other applicable like action, on the part of such Purchaser.
This Agreement has been

5

 

duly executed by such Purchaser, and when delivered by such
Purchaser in accordance with terms hereof, will constitute the valid and legally binding
obligation of such Purchaser, enforceable against it in accordance with its terms, except
(i) as limited by applicable bankruptcy, insolvency, reorganization, or similar laws
relating to or affecting the enforcement of creditors’ rights generally and (ii) as limited
by equitable principles generally.

          (b) Investment Intent. Such Purchaser understands that the Shares are “restricted
securities” and have not been registered under the Securities Act or any applicable state
securities law and is acquiring the Shares as principal for its own account for investment
purposes only and not with a present view to or for distributing or reselling such Shares or
any part thereof, has no present intention of distributing any of such Shares, other than as
set forth herein, and has no arrangement or understanding with any other person or persons
regarding the distribution of such Shares (this representation and warranty not limiting
such Purchaser’s right to sell the Shares in compliance with applicable federal and state
securities laws). Such Purchaser has not engaged, during the one month prior to the date of
this Agreement, in any short sales with respect to the Common Stock. Such Purchaser further
represents that, between the time it became aware of the transactions contemplated by this
Agreement and the public announcement of this Agreement or the termination hereof, it has
not engaged and will not engage in any trades, whether purchases, sales, short sales or
otherwise, with respect to the Common Stock or any other security of the Company.

          (c) Purchaser Status/Residence. At the time such Purchaser was offered the Shares, it
was, and at the date hereof it is an ''accredited investor’’ as defined in Rule 501(a) under
the Securities Act. Such Purchaser is not a registered broker-dealer under Section 15 of the
Exchange Act. Each Purchaser represents that, to the extent that he or she is an individual,
that he or she is a resident of the state set forth opposite his or her name on signature
page, and, to the extent that it is an organizational entity, they it has been organized
under the laws of the state or country set forth opposite its name on signature page.

          (d) Experience of Such Purchaser. Such Purchaser, either alone or together with its
representatives, has such knowledge, sophistication and experience in business and financial
matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Shares, and has so evaluated the merits and risks of such investment. Such Purchaser
is able to bear the economic risk of an investment in the Shares and is able to afford a
complete loss of such investment. Such Purchaser acknowledges that it is familiar with, and
that the Company has made no statements, representations or warranties regarding, the assets
and liabilities, the financial condition and prospects of CHS.

          (e) General Solicitation. Such Purchaser is not purchasing the Shares as a result of
any advertisement, article, notice or other communication regarding the Shares published in
any newspaper, magazine or similar media or broadcast over television or radio or presented
at any seminar or any other general solicitation or general advertisement.

          (f) Access to Information. Such Purchaser acknowledges that it has reviewed the SEC
Reports and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the
terms and conditions of the offering of the Shares and the merits and risks of investing in
the Shares; (ii) the opportunity to have access to information about the Company and its
financial condition, results of operations, business, properties, management and prospects
sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such
additional information that the Company possesses or can acquire without unreasonable effort
or expense that is necessary to make an informed investment decision with respect to
the investment. Neither such inquiries nor any other investigation conducted by or on behalf
of such Purchaser or its representatives or counsel, nor any other provision in any
Transaction Document or the Stock Purchase Agreement, shall modify, amend or affect such
Purchaser’s right to rely on the truth, accuracy and completeness of the SEC Reports and the
Company’s representations and warranties contained in the Transaction Documents.

6

 

          (g) Exemptions from Registration. Such Purchaser understands that the Shares are being
offered and will be sold to it in reliance on specific exemptions from the registration
requirements of the United States federal and state securities laws and that the Company is
relying upon the truth and accuracy of, and the Purchaser’s compliance with, the
representations and warranties of the Purchaser set forth herein in order to determine the
availability of such exemptions and the eligibility of the Purchaser to acquire such Shares.

          (h) No Governmental Approval. Such Purchaser understands that no United States federal
or state agency or any other government or governmental agency has passed on or made any
recommendation or endorsement of the Shares or the fairness or suitability of the investment
in the Shares by the Purchaser nor have such authorities passed upon or endorsed the merits
of the offering of the Shares.

          (i) Unregistered Shares. Such Purchaser understands that the Shares have not been
registered under the Act or any state securities laws and may not be offered for sale, sold,
assigned or transferred unless (i) subsequently registered thereunder or (ii) sold in
reliance on an exemption therefrom.

          (j) No Tax or Legal Advice. Such Purchaser understands that nothing in this Agreement,
any other Transaction Document or any other materials presented to such Purchaser in
connection with the purchase and sale of the Shares constitutes legal, tax or investment
advice. Such Purchaser has consulted such legal, tax and investment advisors as it, in its
sole discretion, has deemed necessary or appropriate in connection with its purchase of
Shares.

ARTICLE IV

OTHER AGREEMENTS OF THE PARTIES

     4.1 Transfer.

          (a) In connection with any transfer of the Shares other than pursuant to an effective
registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser, the
Company may require the transferor thereof to provide to the Company an opinion of counsel
selected by the transferor, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration
of such transferred Shares under the Securities Act. As a condition of transfer, any such
transferee shall agree in writing to be bound by the terms of this Agreement and shall have
the rights of a Purchaser under this Agreement.

          (b) Certificates evidencing the Shares will contain the following legend, until such
time as they are not required under Section 4.1(c):

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE
SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE
OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, AND APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL,
IN A FORM REASONABLY SATISFACTORY TO MBF HEALTHCARE ACQUISITION CORP., THAT
REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS.

          (c) Each Purchaser agrees that the removal of the restrictive legend from certificates
representing Shares as set forth in this Section 4.1 is predicated upon the Company’s
reliance that the Purchaser will sell any Shares pursuant to either the registration
requirements of the Securities Act, including any applicable prospectus delivery
requirements, or an exemption therefrom.

     4.2 Furnishing of Information. As long as any Purchaser owns the Shares, the Company
covenants to timely file (or obtain extensions in respect thereof and file within the applicable
grace period) all reports required to

7

 

be filed by the Company after the date hereof pursuant to the
Exchange Act. As long as any Purchaser owns Shares, if the Company is not required to file reports
pursuant to such laws, it will prepare and furnish to the Purchasers and make publicly available in
accordance with Rule 144(c) such information as is required for the Purchasers to sell such Shares
under Rule 144. The Company further covenants that it will take such further action as any holder
of Shares may reasonably request, all to the extent required from time to time to enable such
Person to sell such Shares without registration under the Securities Act within the limitation of
the exemptions provided by Rule 144.

     4.3 Securities Laws Disclosure; Publicity. By 8:30 a.m. (New York time) on the fourth
Business Day following the date of this Agreement, the Company shall issue a press release
reasonably acceptable to the Purchasers disclosing the transactions contemplated hereby and file a
Current Report on Form 8-K disclosing the material terms of the transactions contemplated hereby.
In addition, the Company will make such other filings and notices in the manner and time required
by the Commission and the Trading Market on which the Common Stock is listed. Notwithstanding the
foregoing, nothing herein shall prevent the Company from selling Shares to additional purchasers,
provided that, the Company shall make the filings and disclosures as required by this Section 4.3,
to the extent required by law.

     4.4 Non-Public Information. The Company covenants and agrees that, following the termination
of the existing confidentiality agreements between the Company and the Purchasers, neither it nor
any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any
information that the Company reasonably believes constitutes material non-public information,
unless prior thereto such Purchaser shall have executed a written agreement regarding the
confidentiality and use of such information. The Company understands and confirms that each
Purchaser shall be relying on the foregoing representations in effecting transactions in securities
of the Company. A definitive proxy statement will be delivered in connection with the CHS
Transaction that will publicly disclose all of the material written information heretofore provided
to the Purchasers by the Company with respect to the Company.

     4.5 Reservation of Stock. As of the date hereof, the Company has reserved and the Company
shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient
number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant
to this Agreement.

     4.6 Listing of Common Stock. The Company hereby agrees to use commercially reasonably efforts
to maintain the listing of the Common Stock on the Trading Market.

     4.7 Registration of Shares.

          (a) On or prior to the Filing Date, the Company shall prepare and file with the
Commission a Registration Statement covering the resale of all of the Shares for an offering
to be made on a continuous basis pursuant to Rule 415, or if Rule 415 is not available for
offers or sales of the Shares, for such other means of distribution of Shares as the
Purchasers may specify. The Registration Statement required hereunder shall be on Form S-3
(except if the Company is not then eligible to register for resale the Shares on Form S-3,
in which case the registration shall be on another appropriate form in accordance herewith).
The Company expects to be eligible by April 4, 2008 to register for resale the Shares on
Form S-3. The Company shall use its commercially reasonable efforts to cause the
Registration Statement to be declared effective under the Securities Act as promptly as
possible after the filing thereof, and shall use its commercially reasonable efforts to keep
such Registration Statement continuously effective under the Securities Act (including the
filing of any necessary amendments, post-effective amendments and supplements) until such
date when all of the Shares (i) have been sold or (ii) may be sold free of volume
restrictions pursuant to Rule 144 promulgated under the Securities Act, as determined by the
counsel to the Company pursuant to a written opinion letter to such effect, addressed and
reasonably acceptable to the
Company’s transfer agent and the affected Purchasers. The Company shall as promptly as
possible telephonically request effectiveness of the Registration Statement as of 5:00 pm
Eastern Time on a Trading Day. The Company shall immediately notify the Purchasers via
facsimile of the effectiveness of a Registration Statement on the same Trading Day that the
Company telephonically confirms effectiveness with the Commission, which shall be the date
requested for effectiveness of the Registration Statement. The Company shall, by 5:30 pm
Eastern Time on the Trading Day after the day the Commission declares the Registration
Statement effective, file a Rule 424(b) prospectus with the Commission.

8

 

          (b) The Company shall pay all expenses arising from or incident to its performance of,
or compliance with, Section 4.7 of this Agreement, including, without limitation, (i)
Commission, stock exchange and Financial Industry Regulatory Authority registration and
filing fees, (ii) all fees and expenses incurred in complying with securities or “blue sky”
laws (including reasonable fees, charges and disbursements of counsel to any underwriter
incurred in connection with “blue sky” qualifications of the Shares as may be set forth in
any underwriting agreement), (iii) all printing, messenger and delivery expenses, (iv) the
fees, charges and expenses of one counsel to the Purchasers not to exceed $25,000, any
necessary counsel with respect to state securities law matters, counsel to the Company and
of its independent public accountants, and any other accounting fees, charges and expenses
incurred by the Company (including, without limitation, any expenses arising from any “cold
comfort” letters or any special audits incident to or required by any registration or
qualification) and any legal fees, charges and expenses incurred by the Purchasers, as the
case may be, and (v) any liability insurance or other premiums for insurance obtained in
connection with the registration contemplated by Section 4.7 of this Agreement, regardless
of whether the Registration Statement is declared effective. All of the expenses described
in the preceding sentence of this Section 7(d) are referred to herein as “Registration
Expenses.”

          (c) The Company agrees to indemnify and hold harmless each Purchaser and, to the extent
such Purchaser is an entity, its partners, directors, officers, affiliates, stockholders,
members, employees, trustees and each Person who controls (within the meaning of Section 15
of the Securities Act) such Purchaser from and against any and all losses, claims, damages,
liabilities and expenses, or any action or proceeding in respect thereof (including
reasonable costs of investigation and reasonable attorneys’ fees and expenses) (each, a
“Liability” and collectively, “Liabilities”), arising out of or based upon (a) any untrue,
or allegedly untrue, statement of a material fact contained in the Disclosure Package, the
Registration Statement, the Prospectus, any Free Writing Prospectus or in any amendment or
supplement thereto; and (b) the omission or alleged omission to state in the Disclosure
Package, the Registration Statement, the Prospectus, any Free Writing Prospectus or in any
amendment or supplement thereto any material fact required to be stated therein or necessary
to make the statements therein not misleading under the circumstances such statements were
made; provided, however, that the Company shall not be held liable in any such case to the
extent that any such Liability arises out of or is based upon an untrue statement or alleged
untrue statement or omission or alleged omission contained in such Disclosure Package,
Registration Statement, Prospectus, Free Writing Prospectus or such amendment or supplement
thereto in reliance upon and in conformity with information concerning such Purchaser
furnished in writing to the Company by or on behalf of such Purchaser expressly for use
therein.

          (d) Any person or entity entitled to indemnification or contribution hereunder (the
“Indemnified Party”) agrees to give prompt written notice to the indemnifying party (the
“Indemnifying Party”) after the receipt by the Indemnified Party of any written notice of
the commencement of any action, suit, proceeding or investigation or threat thereof made in
writing for which the Indemnified Party intends to claim indemnification or contribution
pursuant to this Agreement; provided, however, that the failure to so notify the
Indemnifying Party shall not relieve the Indemnifying Party of any Liability that it may
have to the Indemnified Party hereunder (except to the extent that the Indemnifying Party
forfeits substantive rights or defenses by reason of such failure). If notice of
commencement of any such action is given to the Indemnifying Party as above provided, the
Indemnifying Party shall be entitled to participate in and, to the extent it may wish,
jointly with any other Indemnifying Party similarly notified, to assume the defense of such
action at its own expense, with counsel chosen by it and reasonably satisfactory to such
Indemnified Party. Each Indemnified Party shall have the right to employ separate counsel
in any such action and participate in the defense thereof, but the reasonable and documented
out of pocket fees and expenses of such counsel shall be paid by the Indemnified Party
unless
(i) the Indemnifying Party agrees to pay the same, (ii) the Indemnifying Party fails to
assume the defense of such action with counsel reasonably satisfactory to the Indemnified
Party or (iii) the named parties to any such action (including any impleaded parties)
include both the Indemnifying Party and the Indemnified Party and such parties have been
advised by such counsel that either (x) representation of such Indemnified Party and the
Indemnifying Party by the same counsel would be inappropriate under applicable standards of
professional conduct or (y) there may be one or more legal defenses available to the
Indemnified Party which are different from or additional to those available to the
Indemnifying Party. In any of such cases, the Indemnifying Party shall not have the right
to assume the defense of such action on behalf of such

9

 

Indemnified Party, it being
understood, however, that the Indemnifying Party shall not be liable for the fees and
expenses of more than one separate firm of attorneys (in addition to any local counsel) for
all Indemnified Parties and all fees and expenses shall be reimbursed as incurred. No
Indemnifying Party shall be liable for any settlement entered into without its written
consent, which consent shall not be unreasonably withheld. No Indemnifying Party shall,
without the consent of such Indemnified Party, effect any settlement of any pending or
threatened proceeding in respect of which such Indemnified Party is a party and indemnity
has been sought hereunder by such Indemnified Party, unless such settlement includes an
unconditional release of such Indemnified Party from all liability for claims that are the
subject matter of such proceeding. [Notwithstanding the foregoing, if at any time an
Indemnified Party shall have requested the Indemnifying Party to reimburse the Indemnified
Party for fees and expenses of counsel as contemplated by this Section 9, the Indemnifying
Party agrees that it shall be liable for any settlement of any proceeding effected without
the Indemnifying Party’s written consent if (i) such settlement is entered into more than
thirty (30) business days after receipt by the Indemnifying Party of the aforesaid request
and (ii) the Indemnifying Party shall not have reimbursed the Indemnified Party in
accordance with such request or contested the reasonableness of such fees and expenses prior
to the date of such settlement.]

          (e) If the indemnification provided for in this Section 4.7 from the Indemnifying Party
is unavailable to an Indemnified Party hereunder or insufficient to hold harmless an
Indemnified Party in respect of any Liabilities referred to herein, then the Indemnifying
Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid
or payable by such Indemnified Party as a result of such Liabilities in such proportion as
is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party
in connection with the actions which resulted in such Liabilities, as well as any other
relevant equitable considerations. The relative faults of such Indemnifying Party and
Indemnified Party shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a material fact or
omission or alleged omission to state a material fact, has been made by, or relates to
information supplied by, such Indemnifying Party or Indemnified Party, and the parties’
relative intent, knowledge, access to information and opportunity to correct or prevent such
action. The amount paid or payable by a party as a result of the Liabilities referred to
above shall be deemed to include, subject to the limitations set forth in Sections 4.7(c)
and (d), any reasonable and documented out of pocket legal or other fees, charges or
expenses reasonably incurred by such party in connection with any investigation or
proceeding; provided, that the total amount to be contributed by any Purchaser shall be
limited to the net proceeds received by such Purchaser in the offering.

     4.8 Lock-Up. The Purchasers hereby irrevocably agree that following the Closing and for a
period of 180 days from the Closing (the “Lock-Up Period End Date”), the Purchasers will
not, directly or indirectly:

          (1) offer for sale, sell, pledge or otherwise dispose of or enter into any transaction
or device that is designed to, or could be expected to, result in the disposition by any
person at any time in the future of the Shares;

          (2) enter into any swap or other derivatives transaction that transfers to another, in
whole or in part, any of the economic benefits or risks of ownership of Shares, whether any
such transaction is to be settled by delivery of Shares or other securities, in cash or
otherwise; or

          (3) publicly disclose the intention to do any of the foregoing, for a period commencing
on the date of the Closing and ending on the Lock-Up Period End Date;

provided, that, the provisions of Section 4.8 shall not apply to (a) the registration of the offer
and sale of Common Stock and the sale of the Common Stock in an offering as contemplated by Section
4.7 of this Agreement, (b) bona fide gifts, provided the recipient thereof agrees in writing with
the Company to be bound by the terms of this Section 4.8, (c) in the case of any Purchaser who is
an individual, dispositions to a member of the immediate family of such Purchaser, any trust for
the direct or indirect benefit of such Purchaser and/or the immediate family of such Purchaser (or
a charitable trust) or any entity all of whose interests are held by such Purchaser and/or the
immediate family of such Purchaser (or entities controlled by such persons), provided that such
trust or other entity agrees in writing with the Company to be bound by the terms of this Section
4.8, (d) in the case of any Purchaser who is an individual, dispositions to any beneficiary of such
Purchaser pursuant to a will or other testamentary document or

10

 

applicable laws of descent, provided
that such beneficiary agrees in writing with the Company to be bound to the terms of this Section
4.8, (e) transactions relating to shares of Common Stock or other securities acquired in open
market transactions after the Closing Date or (f) with the Company’s prior written consent.

     4.9 Form D. No later than ten (10) days after the Closing, the Company shall file a Form D
with respect to the Shares as required under Regulation D promulgated under the Securities Act and
shall provide a copy thereof to each Purchaser promptly after filing.

ARTICLE V

MISCELLANEOUS

     5.1 Termination. This Agreement will be null and void and have no further force or effect
upon the termination of the Stock Purchase Agreement.

     5.2 Fees and Expenses. Except as set forth in Section 4.7(b), each Purchaser and the Company
shall pay the fees and expenses of its own advisers, counsel, accountants and other experts, if
any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of the Transaction Documents. The Company shall pay all stamp
and other taxes and duties levied in connection with the issuance of the Shares under this
Agreement.

     5.3 Entire Agreement. The Transaction Documents, together with the Exhibits and Schedules
thereto, contain the entire understanding of the parties with respect to the subject matter hereof
and supersede all prior agreements and understandings, oral or written, with respect to such
matters, which the parties acknowledge have been merged into such documents, exhibits and
schedules.

     5.4 Notices. Any and all notices or other communications or deliveries required or permitted
to be provided hereunder shall be in writing and shall be deemed given and effective on the
earliest of (a) the date of transmission, if such notice or communication is delivered via
facsimile at the facsimile number specified in this Section prior to 5:00 p.m. (New York City time)
on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or
communication is delivered via facsimile at the facsimile number specified in this Section on a day
that is not a Trading Day or later than 5:00 p.m. (New York City time) on any Trading Day, (c) the
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier
service, or (d) upon actual receipt by the party to whom such notice is required to be given. The
address for such notices and communications shall be as follows:

	 	 	 
	If to the Company:

	 	MBF Healthcare Acquisition Corp.
	 

	 	121 Alhambra Plaza, Suite 1100
	 

	 	Coral Gables, Florida 33134
	 

	 	Attn: Miguel B. Fernandez
	 
	 	 
	With a copy to:

	 	Akerman Senterfitt
	 

	 	One Southeast 3rd Avenue
	 

	 	Miami, Florida 33131
	 

	 	Attn: Teddy Klinghoffer, Esq.
	 
	 	 
	If to a Purchaser:

	 	To the address set forth under such Purchaser’s name on the signature pages hereof;

or such other address as may be designated in writing hereafter, in the same manner, by such
Person.

     5.5 Amendments; Waivers. No provision of this Agreement may be waived or amended except in a
written instrument signed by the Company and the Purchaser or Purchasers holding no less than a
majority of the outstanding Shares; provided, however, that if any amendment or waiver adversely
affects any Purchaser or

11

 

Purchasers in a disproportionate manner, then the written consent of any
Purchaser so affected shall also be obtained. No waiver of any default with respect to any
provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in
the future or a waiver of any subsequent default or a waiver of any other provision, condition or
requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder
in any manner impair the exercise of any such right.

     5.6 Construction. The headings herein are for convenience only, do not constitute a part of
this Agreement and shall not be deemed to limit or affect any of the provisions hereof. The
language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party. This
Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of
proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions
of this Agreement or any of the Transaction Documents.

     5.7 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of
the parties and their successors and permitted assigns. The Company may not assign this Agreement
or any rights or obligations hereunder without the prior written consent of the Purchasers. Any
Purchaser may assign any or all of its rights under this Agreement to any Person to whom such
Purchaser assigns or transfers any Shares, provided such transferee agrees in writing to be bound,
with respect to the transferred Shares, by the provisions hereof that apply to the “Purchasers.”

     5.8 No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties
hereto and their respective successors and permitted assigns and is not for the benefit of, nor may
any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8
(as to each Purchaser Party).

     5.9 Governing Law. This Agreement shall be governed and construed in accordance with the
internal laws (without reference to choice or conflict of laws) of the State of New York. Each
party hereby waives all right to a trial by jury in any action, suit or proceeding brought to
enforce or defend any rights or remedies under this Agreement. Each party irrevocably consents to
the service of any and all process in any such action, suit or proceeding by the delivery of such
process to such party at the address and in the manner provided in Section 5.4.

     5.10 Survival. The representations, warranties, agreements and covenants contained herein
shall survive the Closing and the delivery of the Shares.

     5.11 Execution. This Agreement may be executed in two or more counterparts, all of which when
taken together shall be considered one and the same agreement and shall become effective when
counterparts have been signed by each party and delivered to the other party, it being understood
that both parties need not sign the same counterpart. In the event that any signature is delivered
by facsimile transmission, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such
facsimile signature page were an original thereof.

     5.12 Severability. If any provision of this Agreement is held to be invalid or unenforceable
in any respect, the validity and enforceability of the remaining terms and provisions of this
Agreement shall not in any way be affected or impaired thereby and the parties will attempt to
agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so
agreeing, shall incorporate such substitute provision in this Agreement.

     5.13 Replacement of Securities. If any certificate or instrument evidencing any Shares is
mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and
substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new
certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
of such loss, theft or destruction and customary and reasonable indemnity, if requested. The
applicants for a new certificate or instrument under such circumstances shall also pay any
reasonable third-party costs associated with the issuance of such replacement Shares. If a
replacement certificate or instrument evidencing any Shares is requested due to a mutilation
thereof, the Company may require delivery of such mutilated certificate or instrument as a
condition precedent to any issuance of a replacement.

12

 

     5.14 Remedies. In addition to being entitled to exercise all rights provided herein or
granted by law, including recovery of damages, each of the Purchasers and the Company will be
entitled to specific performance under the Transaction Documents. The parties agree that monetary
damages may not be adequate compensation for any loss incurred by reason of any breach of
obligations described in the foregoing sentence and hereby agrees to waive in any action for
specific performance of any such obligation the defense that a remedy at law would be adequate.

     5.15 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each
Purchaser under any Transaction Document are several and not joint with the obligations of any
other Purchaser, and no Purchaser shall be responsible in any way for the performance of the
obligations of any other Purchaser under any Transaction Document. The decision of each Purchaser
to purchase Shares pursuant to the Transaction Documents has been made by such Purchaser
independently of any other Purchaser. Nothing contained herein or in any Transaction Document, and
no action taken by any Purchaser pursuant thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption
that the Purchasers are in any way acting in concert or as a group with respect to such obligations
or the transactions contemplated by the Transaction Document. Each Purchaser acknowledges that no
other Purchaser has acted as agent for such Purchaser in connection with making its investment
hereunder and that no Purchaser will be acting as agent of such Purchaser in connection with
monitoring its investment in the Shares or enforcing its rights under the Transaction Documents.
Each Purchaser shall be entitled to independently protect and enforce its rights, including without
limitation the rights arising out of this Agreement or out of the other Transaction Documents, and
it shall not be necessary for any other Purchaser to be joined as an additional party in any
proceeding for such purpose.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGES FOLLOW]

13

 

     IN WITNESS WHEREOF, the parties hereto have caused this Subscription Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.

	 	 	 	 	 	 	 
	 	 	MBF HEALTHCARE ACQUISITION CORP.	 	 
	 
	 	 	 	 	 	 
	 
	 	/s/ Miguel B. Fernandez 	 	 
	 	 	 	 	 
	 

	 	Name:
	 	Miguel B. Fernandez	 	 
	 

	 	Title:
	 	Chairman and Chief Executive Officer	 	 

Signature Page to MBF Subscription Agreement

 

 

     IN WITNESS WHEREOF, the parties have executed this Subscription Agreement as of the date first
written above.

	 	 	 	 	 	 	 
	 	 	PURCHASERS:	 	 
	 
	 	 	 	 	 	 
	 	 	KOHLBERG INVESTORS V, L.P.	 	 
	 
	 	 	 	 	 	 
	 	 	By: Kohlberg Management V, L.L.C., its general partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	/s/ Gordon Woodward 	 	 
	 

	 	 	 	 

Name: Gordon Woodward
	 	 
	 

	 	 	 	Title: Authorized Representative	 	 

	 	 	 	 	 	 	 	 	 
	 

	 	Number of Shares:
	 	 	2,214,380	 	 	 
	 

	 	Investment Amount:
	 	 

$16,940,010
	 	 
	 

	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	Address of Notice:	 	 	 	 	 	 

	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	KOHLBERG TE INVESTORS V, L.P.	 	 
	 
	 	 	 	 	 	 
	 	 	By: Kohlberg Management V, L.L.C., its general partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	/s/ Gordon Woodward 	 	 
	 

	 	 	 	 

Name: Gordon Woodward
	 	 
	 

	 	 	 	Title: Authorized Representative	 	 

	 	 	 	 	 	 	 	 	 
	 

	 	Number of Shares:
	 	 	1,610,489	 	 	 
	 

	 	Investment Amount:
	 	 

$12,320,245
	 	 
	 

	 	 	 	 

	 	 

	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 
	 

	 	 	 	 	 	 

Signature Page to MBF Subscription Agreement

 

 

	 	 	 	 	 	 	 
	 	 	KOHLBERG OFFSHORE INVESTORS V, L.P.	 	 
	 
	 	 	 	 	 	 
	 	 	By: Kohlberg Management V, L.L.C., its general partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	/s/ Gordon Woodward 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name: Gordon Woodward	 	 
	 

	 	 	 	Title: Authorized Representative	 	 

	 	 	 	 	 	 	 	 	 
	 

	 	Number of Shares:
	 	 	148,330	 	 	 
	 

	 	Investment Amount:
	 	 

$1,134,730
	 	 
	 

	 	 	 	 

	 	 

	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	KOHLBERG PARTNERS V, L.P.	 	 
	 
	 	 	 	 	 	 
	 	 	By: Kohlberg Management V, L.L.C., its general partner	 	 
	 
	 	 	 	 	 	 
	 

	 	 	 	/s/ Gordon Woodward 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name: Gordon Woodward	 	 
	 

	 	 	 	Title:  Authorized Representative	 	 

	 	 	 	 	 	 	 	 	 
	 

	 	Number of Shares:
	 	 	124,691	 	 	 
	 

	 	Investment Amount:
	 	 

$953,888
	 	 
	 

	 	 	 	 

	 	 

	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	KOCO INVESTORS V, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By: Kohlberg Management V, L.L.C., its general partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	/s/ Gordon Woodward 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name: Gordon Woodward	 	 
	 

	 	 	 	Title:  Authorized Representative	 	 

	 	 	 	 	 	 	 	 	 
	 

	 	Number of Shares:
	 	 	97,798	 	 	 
	 

	 	Investment Amount:
	 	 

$748,158
	 	 
	 

	 	 	 	 

	 	 

	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 
	 

	 	 	 	 	 	 

Signature Page to MBF Subscription Agreement

 

 

	 	 	 	 	 	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	S.A.C. DOMESTIC INVESTMENTS, L.P.	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	By:	 	S.A.C. Capital Management, LLC,	 	 
	 	 	 	 	Its General Partner	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	By:	 	/s/ Peter Nussbaum 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Name: Peter Nussbaum	 	 	 	 	 	 
	 

	 	 	 	Title: Authorized Signatory	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Number of Shares:	 	 	25,118	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	Investment Amount:	 	 	$192,155	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	BLACKSTONE MEZZANINE PARTNERS II, L.P.	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	By:	 	Blackstone Mezzanine Associates II L.P.,	 	 
	 	 	 	 	Its General Partner	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	By:	 	Blackstone Mezzanine Management Associates II L.L.C.,	 	 
	 	 	 	 	Its General Partner	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	By:	 	/s/ Salvatore Gentile 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Name: Salvatore Gentile	 	 	 	 	 	 
	 

	 	 	 	Title: Authorized Signer

	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Number of Shares:	 	 	96,457	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	Investment Amount:	 	 	$737,897	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 

Signature Page to MBF Subscription Agreement

 

 

	 	 	 	 	 	 	 	 	 	 	 
	 	 	BLACKSTONE MEZZANINE HOLDINGS II, L.P.	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	By:	 	Blackstone Mezzanine Associates II L.P.,	 	 
	 	 	 	 	Its General Partner	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	By:	 	Blackstone Mezzanine Management Associates II L.L.C.,	 	 
	 	 	 	 	Its General Partner	 	 
	 
	 

	 	By:	 	/s/ Salvatore Gentile 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Name: Salvatore Gentile	 	 	 	 	 	 
	 

	 	 	 	Title: Authorized Signer	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Number of Shares:	 	 	4,016	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	Investment Amount:	 	$	30,725	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	By:	 	/s/ Nitin Patel 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Nitin Patel	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Number of Shares:	 	 	20,068	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	Investment Amount:	 	$	153,527	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	By:	 	/s/ Robert Cucuel 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Robert Cucuel	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Number of Shares:	 	 	137,755	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	Investment Amount:	 	$	1,053,830	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 

Signature Page to MBF Subscription Agreement

 

 

	 	 	 	 	 	 	 	 	 	 	 
	 

	 	By:	 	/s/ Mary Jane Graves 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	Mary Jane Graves	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Number of Shares:	 	 	53,884	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	Investment Amount:	 	$	412,220	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	By:	 	/s/ Chuck Brown 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Chuck Brown	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Number of Shares:	 	 	4,974	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	Investment Amount:	 	$	38,054	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	By:	 	/s/ Colleen Lederer 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Colleen Lederer	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Number of Shares:	 	 	11,707	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	Investment Amount:	 	$	89,561	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 

Signature Page to MBF Subscription Agreement

 

 

	 	 	 	 	 	 	 	 	 	 	 
	 

	 	By:	 	/s/ Jonathan Manin 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Jonathan Manin	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Number of Shares:	 	 	7,052	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	Investment Amount:	 	$	53,952	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	By:	 	/s/ Joey Ryan 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Joey Ryan	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Number of Shares:	 	 	18,437	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	Investment Amount:	 	$	141,048	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	Address of Notice:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Tel:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Fax:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 

Signature Page to MBF Subscription Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}]]